Spending Review – NHS must invest more in proven innovations, says ABPI
The government spending review has concluded with a 3% per year increase for health and the NHS. As part of fixing the broken NHS, the innovative pharmaceutical industry is calling for greater focus…
Read the full articleYou might also wanna read
€1 in, €5.67 out: How spending on medicines pays back in Europe’s health and economic future
Europe’s spending on innovative medicines buys more than health. A new report shows that every euro returns more than five times in economic
UK Government invests in 10-year NHS plan that will modernise the healthcare service
The UK government has announced a 10-year capital investment plan aimed at transforming the NHS by upgrading hospitals, expanding GP surgeri
NHS Fast-tracks Life-changing Medicines in Landmark UK-US Access Overhaul
A new series of NHS pilot schemes could give patients access to innovative medicines months earlier while supporting investment in the UK's
UK Life Sciences Must Move From Innovation Pilots to National Adoption
The UK is not short of innovation. The challenge is building the national systems, funding routes and procurement models needed to turn prom
Campaign opposes cutting NHS and education budgets to fund defence spending increase
Starmer wants to gut the NHS and education budget to increase defence spending. It's outrageous and we need to show him just how unpopular t
38d.gs·1mo ago
Why single-payer health systems may struggle with cutting-edge biomedical innovation
That is the theme of my latest Free Press piece, here is one excerpt from it: Government-run systems often (not always) do a perfectly fine
marginalrevolution.com·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.